DVA Stock Recent News
DVA LATEST HEADLINES
DaVita (DVA), Minerals Technologies (MTX), Alphabet (GOOGL) and Garmin (GRMN) have been selected as the momentum picks for the day using the Driehaus strategy.
Does DaVita HealthCare (DVA) have what it takes to be a top stock pick for momentum investors? Let's find out.
Despite the macroeconomic challenges, dependence on telehealth and AI dominance are likely to drive the Zacks Medical - Outpatient and Home Healthcare industry. DVA, EHC, OPCH and PNTG are well-poised to gain.
Here is how DaVita HealthCare (DVA) and Alcon (ALC) have performed compared to their sector so far this year.
We have narrowed our search to outpatient and home healthcare stocks that have strong growth potential for 2024. These are: DVA, ADUS, OPCH, EHC, PNTG.
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
ROOT, SMCI, PPC, DFH and DVA have been added to the Zacks Rank #1 (Strong Buy) List on May 6, 2024.
DaVita's (DVA) robust segmental revenues drive its first-quarter performance.
DaVita HealthCare (DVA) came out with quarterly earnings of $2.38 per share, beating the Zacks Consensus Estimate of $1.96 per share. This compares to earnings of $1.58 per share a year ago.
DaVita raised its annual profit forecast on Thursday banking on strong demand for its kidney dialysis services, sending its shares up 3.7% in trading after the bell.